Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The EU financial services commissioner is due to meet Bank of England governor Andrew Bailey on Monday....
...That an mRNA approach (also favoured by Pfizer and BioNTech) can produce antibodies is a decent proof of concept that the accelerated development pathway might, just might, work....
...The defeat puts PPG in good company, joining a list that includes Kraft Heinz, Pfizer and Monsanto — all of whom were unsuccessful at striking a friendly deal in the old continent....
...Chairman Leif Johansson triggered a paper loss last year when he rebuffed a £55-a-share bid from Pfizer. The shares remain £10 cheaper....
...She was namechecked at the very end when the chairman, Adrian Bailey, thanked Mr Read for turning up. “A pleasure to be here,” he replied....
...pharmaceuticals group Pfizer....
...Adrian Bailey, chairman of the business select committee which grilled the executives of both companies last week, said he wanted the government to come up with a workable public interest test “to pre-empt...
...The tone of the 81-minute grilling was set when the chair of the select committee, Adrian Bailey, noted that Pfizer had been called a “praying mantis” and “a shark that needs feeding”....
...But Christopher Bailey, incoming and open-collared chief executive of Burberry, made clear to the City that he would be “unconventional”....
...“We have been bitten once before on Kraft/Cadbury,” said Mr Bailey, referring to US-based Kraft’s breaking of job pledges made before its takeover of Cadbury of the UK in 2010....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
...The biggest growth, however, came from ready to drink, where the US launch of Smirnoff Twisted V pushed organic growth up 7 per cent....
International Edition